OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Eric L. Simpson, B. Lockshin, Lara Wine Lee, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 1, pp. 261-270
Open Access | Times Cited: 6
Eric L. Simpson, B. Lockshin, Lara Wine Lee, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 1, pp. 261-270
Open Access | Times Cited: 6
Showing 6 citing articles:
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study
Stephan Weidinger, Tobias Schadeck, Felix Jacobs, et al.
Dermatology and Therapy (2025)
Open Access
Stephan Weidinger, Tobias Schadeck, Felix Jacobs, et al.
Dermatology and Therapy (2025)
Open Access
Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry
Neal Bhatia, Charles Lynde, Luz Fonacier, et al.
Dermatology and Therapy (2025)
Open Access
Neal Bhatia, Charles Lynde, Luz Fonacier, et al.
Dermatology and Therapy (2025)
Open Access
Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
Laure Migayron, Sylvie Bordes, B. Closs, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Laure Migayron, Sylvie Bordes, B. Closs, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Current and Emerging Biologics for Atopic Dermatitis
Michael Z. Nevid, Mark Boguniewicz
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 577-594
Closed Access | Times Cited: 1
Michael Z. Nevid, Mark Boguniewicz
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 577-594
Closed Access | Times Cited: 1
One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis
Piergiacomo Calzavara-Pinton, Chia‐Yu Chu, Hilde Lapeere, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 720-733
Open Access | Times Cited: 1
Piergiacomo Calzavara-Pinton, Chia‐Yu Chu, Hilde Lapeere, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 720-733
Open Access | Times Cited: 1
